Nissui Corporation

Equities

1332

JP3718800000

Food Processing

Delayed Japan Exchange 22:30:00 2024-05-08 EDT 5-day change 1st Jan Change
952.4 JPY +0.66% Intraday chart for Nissui Corporation -0.70% +25.46%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Nissui Merges Consolidated Subsidiaries, Rename Merged Entity MT
Nissui to Merge Food Subsidiaries MT
Nissui Corp.’s Attributable Profit Climbs 9.2% in Fiscal Nine Months MT
Japan's Nikkei softens on profit-taking as investors weigh earnings RE
Nissui Corporation Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024 CI
Nissui Corporation acquired Maxima Seafood B.V. CI
China's ban on Japanese seafood has more political than economic heft RE
Nissui Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024 CI
Immersion Technologies Australia Pty Limited announced that it has received funding from Nissui Corporation CI
Nissui Corporation Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Nissui Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024 CI
Bank Earnings in Focus as US Equity Futures Tread Water MT
Nippon Suisan Kaisha, Ltd. will Change its Name to Nissui Corporation CI
Nippon Suisan Kaisha, Ltd. Revises Earnings Guidance for the Fiscal Year Ending March 31, 2023 CI
Tranche Update on Nissui Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 31, 2022. CI
Tranche Update on Nissui Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 31, 2022. CI
Nissui Pharmaceutical Co., Ltd.'s Equity Buyback announced on May 31, 2022 has closed with 12,552,248 shares, representing 55.67% for ¥20,861.84 CI
Nippon Suisan Kaisha, Ltd. Provides Earnings Guidance for the Fiscal Year Ending March 31, 2023 CI
Nikkei 225 Up 0.5% as Tech Issues Gain; Pandemic Caps Upside MT
Nikkei 225 Down 1.8% on Pandemic, Price Outlooks MT
Japanese stocks fall as rising COVID cases spark recession fears RE
Japanese shares fall as recession fears resurface RE
Nissui Pharmaceutical Co., Ltd. announces an Equity Buyback for 13,237,063 shares, representing 58.71% for ¥22,000 million. CI
Nippon Suisan Kaisha, Ltd. Provides Earnings Guidance for the Fiscal Year Ending March 31, 2023 CI
Nippon Suisan Kaisha, Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2022 CI
Chart Nissui Corporation
More charts
Nissui Corporation (formerly Nippon Suisan Kaisha, Ltd.) is one of the Japanese largest food processing groups. Net sales break down as follows: - manufacturing and sale of food products (48.9%): primarily frozen products and canned products; - processing and sale of sea products (42%); - manufacturing and sale of fine chemical products (3.9%): pharmaceutical raw materials, functional raw materials, functional foods, pharmaceutical products and clinical diagnostic products; - transportation, cold storage and warehousing services (2.4%); - other (2.8%): primarily construction, operating and repair of vessels. Net sales are distributed geographically as follows: Japan (64.3%), North America (16.2%), Europe (15.9%) and other (3.6%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
946.2 JPY
Average target price
1,080 JPY
Spread / Average Target
+14.14%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW